$CSPI

CSP Inc. Q3 2026 Earnings Call Summary

CSP Inc. reported Q3 2026 call updates: Technology Solutions revenue was pressured by hardware vendor delivery delays, pushing backlog up 65% YoY. AZT Protect is shifting to larger enterprise accounts with 18-24 month cycles and maintains 100% renewal and zero breaches. Management expects supply constraints to persist about a year and targets Acronis OEM launch by Oct 1, 2026.

Original reporting
Published Aug 14, 2026, 5:45 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 14, 2026, 6:14 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
CSP Inc. Q3 2026 Earnings Call Summary — source image
Decision brief

The 30-second read

$CSPINeutralMed
01

Why it matters

Key decision points for traders are the persistence of hardware supply constraints, the timing uncertainty around the Acronis OEM launch, and the near-term margin and loss drivers from compensation and UK pension transaction costs.

02

Market read

The call provides concrete operational metrics (backlog, renewals, breaches) and forward-looking timing (hardware constraints for at least a year, Acronis launch by Oct 1, 2026) that can shift revenue timing expectations.

03

What to watch

The Acronis OEM rollout lacks a revenue estimate because partner-controlled timelines, which increases uncertainty around near-term growth contribution despite the targeted Oct 1, 2026 launch.

Relevance 6/10Novelty 6/10Timing: ahead of/into Q3 2026 earnings positioning, with OEM launch timing into Oct 1, 2026

Background

This is a Q3 2026 earnings call summary focused on CSPi’s OT security AZT Protect, Technology Solutions hardware delivery timing, and an Acronis OEM integration.

Company-level read

Ticker impact

$CSPINeutralMedium confidence
Context

CSPi said hardware delivery delays pushed Technology Solutions backlog up 65% YoY and expects constraints to persist for at least another year.

Expected impact

Near-term sentiment likely mixed: backlog and renewals are positives, but persistent delivery constraints and operating loss pressure can cap upside.

Evidence & confidence

The article provides specific operational metrics (65% backlog increase, 100% renewal, zero breaches) alongside a forward-looking constraint duration and an operating loss increase tied to compensation and pension transaction costs.

Market effects

Enterprise OT cybersecurity demand appears resilient, but near-term revenue timing is being distorted by hardware supply constraints.

South African telecom deployments and UFT utility pilots suggest continued traction in non-US enterprise segments.

AI infrastructure build-outs are cited as a driver of component shortages, linking CSPi’s delivery outlook to global capex cycles.

Counterpoint

The 65% backlog increase may reflect delayed shipments rather than incremental bookings, so revenue conversion could lag even if renewals remain strong.

Key entities

  • CSPI

    CSPi, discussed across backlog growth, AZT Protect renewal performance, Acronis OEM integration timing, and operating loss drivers.

  • Acronis

    OEM integration partner for AZT Protect, targeted for full commercial launch by Oct 1, 2026.

  • UFT

    Water and wastewater utility partner progressing through validation and pilots, with new initiatives teased in 2-3 weeks.

Related articles

$CSPIMed

CSPi Reports FY2026 Third Quarter Results

CSP INC /MA/ (CSPI) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 CSPi Reports FY2026 Third Quarter Results AZT PROTECT Performance and High Customer Satisfaction Generates 100% Renewal Rate; TS Order Backlog Continues Year-Over-Year Growth; Recent Surge of Large Cloud-based Services Contracts Combine with AZT PROTECT & TS Opportun

$AAMedAI 8/10

Why Alcoa Stock Popped on Friday

Alcoa (AA) reported Q3 earnings of $1.82 per share, beating estimates of $1.54. Sales were $3.7B, slightly below expectations. The company grew sales by 23.7%, improved profit margins, and generated $472M in free cash flow. Management reaffirmed annual production targets but noted potential cost pressures. Analysts expect $6.81 EPS for 2026.

$HOMBMed

Home BancShares (HOMB) Q3 2026 Earnings Call Transcript

Home BancShares (HOMB) reported Q3 2026 earnings, highlighting a 9.5% dividend increase to $0.23/share, $39.3M in share buybacks (0.69% yield), and strong profitability. The company emphasized its disciplined balance sheet strategy, avoiding long-duration securities, and managing AOCI impact. Key metrics include a 4.53% net interest margin, 2.11% ROA, and 16.54% return on tangible common equity. Management expects recoveries on a large nonperforming loan and plans continued stock repurchases.

$BNYMedAI 8/10

BNY (BNY) Q3 2026 Earnings Call Transcript

BNY Mellon reported Q3 2026 earnings with total revenue of $5.7B, up 12% YoY. Fee revenue also rose 12%, driven by investment services and foreign exchange. AUC/A reached $63.4T, up 10% YoY. The company highlighted growth in digital assets and AI integration, with new product launches and partnerships. Expenses increased 8% YoY, largely due to revenue-related costs and strategic investments.